FMP

FMP

Enter

VMD - Viemed Healthcare, I...

photo-url-https://images.financialmodelingprep.com/symbol/VMD.png

Viemed Healthcare, Inc.

VMD

NASDAQ

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

6.61 USD

0.08 (1.21%)

Operating Data

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

131.31M

117.06M

138.83M

183.01M

224.26M

259.08M

299.3M

345.77M

399.46M

461.48M

Revenue %

-

-10.85

18.6

31.82

22.54

15.53

15.53

15.53

15.53

Ebitda

30.54M

21.84M

24.03M

36.71M

16.73M

44.94M

51.92M

59.98M

69.3M

80.06M

Ebitda %

23.25

18.66

17.31

20.06

7.46

17.35

17.35

17.35

17.35

Ebit

20.95M

10.53M

8.4M

14.84M

15.25M

23.79M

27.48M

31.75M

36.68M

42.37M

Ebit %

15.96

8.99

6.05

8.11

6.8

9.18

9.18

9.18

9.18

Depreciation

9.58M

11.31M

15.63M

21.86M

1.48M

21.15M

24.44M

28.23M

32.62M

37.68M

Depreciation %

7.3

9.66

11.26

11.95

0.66

8.17

8.17

8.17

8.17

Balance Sheet

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Total Cash

30.98M

28.41M

16.91M

12.84M

17.54M

38.8M

44.82M

51.78M

59.82M

69.11M

Total Cash %

23.59

24.27

12.18

7.02

7.82

14.98

14.98

14.98

14.98

Receivables

12.37M

14.72M

15.4M

18.45M

24.91M

28.13M

32.49M

37.54M

43.37M

50.1M

Receivables %

9.42

12.57

11.1

10.08

11.11

10.86

10.86

10.86

10.86

Inventories

2.31M

2.46M

3.57M

4.63M

4.32M

5.64M

6.52M

7.53M

8.7M

10.05M

Inventories %

1.76

2.1

2.57

2.53

1.93

2.18

2.18

2.18

2.18

Payable

2.1M

3.24M

2.65M

7.41M

9.34M

7.51M

8.67M

10.02M

11.57M

13.37M

Payable %

1.6

2.77

1.91

4.05

4.16

2.9

2.9

2.9

2.9

Cap Ex

-13.04M

-19.74M

-22.9M

-26.09M

-37.77M

-38.55M

-44.53M

-51.45M

-59.43M

-68.66M

Cap Ex %

-9.93

-16.87

-16.49

-14.26

-16.84

-14.88

-14.88

-14.88

-14.88

Weighted Average Cost Of Capital

Price

6.61

Beta

Diluted Shares Outstanding

40.81M

Costof Debt

11.3

Tax Rate

After Tax Cost Of Debt

7.87

Risk Free Rate

Market Risk Premium

Cost Of Equity

Total Debt

6.87M

Total Equity

269.72M

Total Capital

276.59M

Debt Weighting

2.48

Equity Weighting

97.52

Wacc

11.8

Build Up Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

131.31M

117.06M

138.83M

183.01M

224.26M

259.08M

299.3M

345.77M

399.46M

461.48M

Ebitda

30.54M

21.84M

24.03M

36.71M

16.73M

44.94M

51.92M

59.98M

69.3M

80.06M

Ebit

20.95M

10.53M

8.4M

14.84M

15.25M

23.79M

27.48M

31.75M

36.68M

42.37M

Tax Rate

30.33

30.33

30.33

30.33

30.33

30.33

30.33

30.33

30.33

30.33

Ebiat

25.06M

7.68M

5.81M

10.57M

10.62M

18.22M

21.05M

24.32M

28.1M

32.46M

Depreciation

9.58M

11.31M

15.63M

21.86M

1.48M

21.15M

24.44M

28.23M

32.62M

37.68M

Receivables

12.37M

14.72M

15.4M

18.45M

24.91M

28.13M

32.49M

37.54M

43.37M

50.1M

Inventories

2.31M

2.46M

3.57M

4.63M

4.32M

5.64M

6.52M

7.53M

8.7M

10.05M

Payable

2.1M

3.24M

2.65M

7.41M

9.34M

7.51M

8.67M

10.02M

11.57M

13.37M

Cap Ex

-13.04M

-19.74M

-22.9M

-26.09M

-37.77M

-38.55M

-44.53M

-51.45M

-59.43M

-68.66M

Ufcf

9.01M

-2.09M

-3.85M

6.99M

-29.89M

-5.54M

-3.12M

-3.6M

-4.16M

-4.81M

Wacc

11.8

11.8

11.8

11.8

11.8

Pv Ufcf

-4.95M

-2.49M

-2.58M

-2.66M

-2.75M

Sum Pv Ufcf

-15.44M

Terminal Value

Growth In Perpetuity Method

Long Term Growth Rate

Wacc

11.8

Free Cash Flow T1

-4.9M

Terminal Value

-50.01M

Present Terminal Value

-28.63M

Intrinsic Value

Enterprise Value

-44.07M

Net Debt

-10.67M

Equity Value

-33.4M

Diluted Shares Outstanding

40.81M

Equity Value Per Share

-0.82

Projected DCF

-0.81842 9.077%

DCF Levered

Download Excel

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep